RNA Targeting Small Molecule Drug Discovery Global Market Report 2026
상품코드:1957760
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
RNA를 표적으로 하는 저분자 의약품 개발 시장 규모는 최근 급격하게 확대되고 있습니다. 2025년 21억 3,000만 달러에서 2026년에는 26억 달러에 이르고, CAGR 22.3%의 성장이 전망되고 있습니다. 지금까지의 성장은 단백질 표적의 약물화 가능성의 한계, 유전성 질환의 유병률 증가, RNA 생물학 연구의 발전, 산학협력의 확대, RNA 기반 치료제의 초기 단계의 성공 등이 그 요인으로 꼽힙니다.
RNA 표적저분자 Drug Discovery 시장 규모는 향후 몇 년간 급격한 성장이 전망됩니다. 2030년에는 60억 4,000만 달러에 이르고, CAGR은 23.5%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 AI를 활용한 RNA 표적 식별, 정밀의료에 대한 투자 증가, RNA 치료제 파이프라인 확대, RNA 전달 기술 향상, 새로운 치료법에 대한 규제적 지원 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 AI 기반 RNA 구조 예측, RNA 표적 종양학 파이프라인의 확대, RNA 특이적 소분자 라이브러리의 발전, RNA 결합 선택성 및 특이성 향상, RNA 신약개발의 멀티오믹스 통합 등을 들 수 있습니다.
암, 유전성 질환, 바이러스 감염증의 발생률 증가는 향후 몇 년 동안 RNA 표적 저분자 의약품 개발 시장의 성장을 뒷받침할 것으로 예측됩니다. 암은 체내에서 통제할 수 없는 세포 증식을 특징으로 하는 일련의 질병입니다. 바이러스 감염은 살아있는 세포 내에서만 증식하는 미세한 감염 인자인 바이러스에 의해 발생합니다. RNA 표적형 신약개발은 암, 유전질환, 바이러스 감염증의 치료에 적용됩니다. 이들 질환은 RNA 표적 접근법으로 개발된 약물로 치료할 수 있는 유전자 이상이나 기능 장애와 관련이 있기 때문입니다. 예를 들어, 스위스에 본부를 둔 국제기구인 세계보건기구(WHO)가 2024년 2월 발표한 보고서에 따르면, 2022년 전 세계적으로 약 2,000만 건의 신규 암 발병과 970만 건의 암 관련 사망이 기록될 것으로 예상했습니다. 폐암이 250만 건(12.4%)으로 가장 많았고, 여성 유방암이 230만 건(11.6%), 대장암 190만 건(9.6%), 전립선암 150만 건(7.3%), 위암 97만 건(4.9%) 순이었습니다. 2050년까지 신규 암 발생 건수는 77% 증가하여 연간 3,500만 건을 넘어설 것으로 예측되고 있습니다. 그 결과, 암, 유전성 질환, 바이러스 감염증의 유병률 증가가 RNA를 표적으로 하는 저분자 의약품 개발 시장의 성장을 가속하고 있습니다.
RNA 표적 소분자 신약 시장에서 사업을 전개하는 주요 기업들은 경쟁 우위를 강화하기 위해 SaaS(Software as a Service) 플랫폼과 같은 첨단 솔루션을 도입하고 있습니다. SaaS는 소프트웨어 용도를 외부 공급자가 호스팅하고 사용자가 인터넷을 통해 접속하는 제공 모델입니다. 예를 들어, 2023년 12월, 미국에 본사를 둔 과학기술 기업 머크 앤 컴퍼니(Merck & Company)는 AIDDISON을 출범했습니다. 이 플랫폼은 선별된 약물 후보물질의 합성에 최적의 방법을 제안합니다. 이러한 접근방식은 신약개발 관련 비용을 크게 절감하고, 새로운 치료법을 환자에게 전달할 수 있는 성공 확률을 높일 수 있는 잠재력을 가지고 있습니다. 이 플랫폼은 가상 분자 설계와 실용적인 제조 가능성을 결합하여 대규모 데이터 세트에서 귀중한 인사이트를 도출하고 치료 제공을 강화할 수 있습니다. 이 AI 기반 시스템은 컴퓨터 지원 의약품 설계, 머신러닝, 생성형 인공지능을 통합하여 의약품 개발 일정을 가속화합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
RNA-targeting small-molecule drug discovery involves the identification and development of small-molecule compounds that bind to RNA molecules to influence their function or activity. This approach supports the development of novel therapies for the treatment of multiple conditions, including genetic disorders, viral infections, neurodegenerative diseases, and cancer.
The main type of RNA-targeting small-molecule drug discovery include messenger RNA (mRNA), non-coding RNA (ncRNA), microRNA (miRNA), and long non-coding RNA (lncRNA). Messenger RNA (mRNA) is an RNA molecule responsible for transferring genetic information from DNA in the cell nucleus to ribosomes, where proteins are synthesized. The technologies used include CRISPR-Cas9, RNA aptamers, small interfering RNA (siRNA), ribozymes, and other approaches applied across several therapeutic areas such as oncology, neurology, infectious diseases, metabolic disorders, genetic conditions, and others. Delivery methods include intravenous (IV), oral, topical, and other routes, and these solutions are utilized for research, therapeutic, diagnostic, and other applications.
Tariffs have influenced the rna targeting small molecule drug discovery market by increasing costs of imported laboratory instruments, specialized reagents, and high-throughput screening technologies used in early-stage research. these impacts are most pronounced across research use and therapeutic development segments, particularly in regions dependent on cross-border biotech supply chains such as asia-pacific and europe. oncology and genetic disorder pipelines face longer development timelines due to higher input costs. however, tariffs are also encouraging localized manufacturing, regional r&d expansion, and strategic sourcing, which may strengthen domestic innovation ecosystems over the long term.
The rna targeting small molecule drug discovery market research report is one of a series of new reports from The Business Research Company that provides rna targeting small molecule drug discovery market statistics, including rna targeting small molecule drug discovery industry global market size, regional shares, competitors with a rna targeting small molecule drug discovery market share, detailed rna targeting small molecule drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the rna targeting small molecule drug discovery industry. This rna targeting small molecule drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The rna targeting small molecule drug discovery market size has grown exponentially in recent years. It will grow from $2.13 billion in 2025 to $2.6 billion in 2026 at a compound annual growth rate (CAGR) of 22.3%. The growth in the historic period can be attributed to limited druggability of protein targets, rising prevalence of genetic disorders, advances in rna biology research, growth in academic-industry collaborations, early success of rna-based therapeutics.
The rna targeting small molecule drug discovery market size is expected to see exponential growth in the next few years. It will grow to $6.04 billion in 2030 at a compound annual growth rate (CAGR) of 23.5%. The growth in the forecast period can be attributed to ai-enabled rna target identification, increasing investment in precision medicine, expansion of rna therapeutics pipelines, improved rna delivery technologies, regulatory support for novel modalities. Major trends in the forecast period include ai-driven rna structure prediction, expansion of rna-targeted oncology pipelines, advances in rna-specific small molecule libraries, improved rna binding selectivity and specificity, integration of multi-omics in rna drug discovery.
The rising incidence of cancer, genetic disorders, and viral infections is expected to support the expansion of the RNA-targeted small-molecule drug discovery market in the coming years. Cancer encompasses a range of diseases marked by uncontrolled cell growth within the body. Viral infections are caused by viruses, which are microscopic infectious agents that replicate only inside living cells. RNA-targeted drug discovery is applied in the treatment of cancer, genetic disorders, and viral infections because these conditions are associated with genetic abnormalities or dysfunctional genetic material, which can be addressed using drugs developed through RNA-targeting approaches. For example, in February 2024, according to a report released by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded worldwide in 2022. Lung cancer accounted for the highest number of cases at 2.5 million (12.4%), followed by female breast cancer with 2.3 million cases (11.6%), colorectal cancer with 1.9 million cases (9.6%), prostate cancer with 1.5 million cases (7.3%), and stomach cancer with 970,000 cases (4.9%). By 2050, the number of new cancer cases is projected to increase by 77%, exceeding 35 million annually. As a result, the growing prevalence of cancer, genetic disorders, and viral infections is driving the growth of the RNA-targeted small-molecule drug discovery market.
Key companies operating in the RNA-targeting small-molecule drug discovery market are introducing advanced solutions such as software-as-a-service platforms to strengthen their competitive position. Software-as-a-service (SaaS) is a delivery model in which software applications are hosted by external providers and accessed by users through the Internet. For instance, in December 2023, Merck & Co. Inc., a US-based science and technology company, launched AIDDISON. This platform recommends optimal methods for synthesizing selected drug candidates. Such an approach has the potential to significantly reduce costs associated with drug discovery and improve the likelihood of successfully bringing new therapies to patients. By connecting virtual molecular design with practical manufacturability, the platform enhances treatment delivery by uncovering valuable insights from large datasets. To accelerate drug development timelines, this AI-driven system combines computer-aided drug design, machine learning, and generative artificial intelligence.
In June 2025, Novartis AG, a Switzerland-based company specializing in pharmaceuticals, gene therapies, and innovative medicines, acquired Regulus Therapeutics Inc. for up to $1.7 billion. This acquisition is intended to reinforce Novartis's renal disease pipeline by gaining access to Regulus's lead microRNA inhibitor for autosomal dominant polycystic kidney disease (ADPKD) and advancing its capabilities in RNA-targeted drug discovery. Regulus Therapeutics Inc. is a US-based clinical-stage biopharmaceutical company focused on discovering and developing therapies that target microRNAs.
Major companies operating in the rna targeting small molecule drug discovery market are F. Hoffmann-La Roche Ltd, Novartis AG, Bristol-Myers Squibb Company, Moderna Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics, Arbutus Biopharma Corporation, Arbutus Biopharma Corporation
North America was the largest region in the RNA-targeting small molecule drug discovery market in 2025. The regions covered in the rna targeting small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the rna targeting small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The RNA targeting small molecule drug discovery market consists of revenues earned by entities by providing hit identification, hit validation, and hit characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The RNA-targeting small molecule drug discovery market also includes sales of asRNAs and siRNAs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
RNA Targeting Small Molecule Drug Discovery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses rna targeting small molecule drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rna targeting small molecule drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rna targeting small molecule drug discovery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Target RNA Type: Messenger RNA (mRNA); Non-Coding RNA (ncRNA); MicroRNA (miRNA); Long Non-Coding RNA (lncRNA)
2) By Therapeutic Area: Oncology; Neurology; Infectious Disease; Metabolic Diseases; Genetic Disorders; Other Therapeutic Areas
3) By Delivery Method: Intravenous (IV); Oral; Topical; Other Methods
4) By Application: Research Use; Therapeutic Use; Diagnostic Use; Other Applications
Subsegments:
1) By Messenger RNA (mRNA): Targeting mRNA For Protein Coding; Modulation Of mRNA Stability; mRNA Translation Inhibition
2) By Non-Coding RNA (ncRNA): Long Non-Coding RNA; Small Nuclear RNA; Small Nucleolar RNA
3) By MicroRNA (miRNA): miRNA Inhibition; miRNA Mimics; Targeting Specific miRNA Pathways
4) By Long Non-Coding RNA (lncRNA): lncRNA Modulators; Targeting Specific lncRNA Functions; Therapeutic Applications Of lncRNA
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.2 Expansion Of RNA-Targeted Oncology Pipelines
4.2.3 Advances In RNA-Specific Small Molecule Libraries
4.2.4 Improved RNA Binding Selectivity And Specificity
4.2.5 Integration Of Multi-Omics In RNA Drug Discovery
5. RNA Targeting Small Molecule Drug Discovery Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Biotechnology Companies
5.3 Academic And Research Institutes
5.4 Contract Research Organizations (CROs)
5.5 Diagnostic Laboratories
6. RNA Targeting Small Molecule Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global RNA Targeting Small Molecule Drug Discovery Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global RNA Targeting Small Molecule Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global RNA Targeting Small Molecule Drug Discovery Market Size, Comparisons And Growth Rate Analysis
7.3. Global RNA Targeting Small Molecule Drug Discovery Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global RNA Targeting Small Molecule Drug Discovery Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global RNA Targeting Small Molecule Drug Discovery Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. RNA Targeting Small Molecule Drug Discovery Market Segmentation
9.1. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.2. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
9.3. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Intravenous (IV), Oral, Topical, Other Methods
9.4. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Research Use, Therapeutic Use, Diagnostic Use, Other Applications
9.5. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Messenger RNA (mRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Targeting mRNA For Protein Coding, Modulation Of mRNA Stability, mRNA Translation Inhibition
9.6. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Non-Coding RNA (ncRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Long Non-Coding RNA, Small Nuclear RNA, Small Nucleolar RNA
9.7. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of MicroRNA (miRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
miRNA Inhibition, miRNA Mimics, Targeting Specific miRNA Pathways
9.8. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Long Non-Coding RNA (lncRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
lncRNA Modulators, Targeting Specific lncRNA Functions, Therapeutic Applications Of lncRNA
10. RNA Targeting Small Molecule Drug Discovery Market Regional And Country Analysis
10.1. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market
11.1. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China RNA Targeting Small Molecule Drug Discovery Market
12.1. China RNA Targeting Small Molecule Drug Discovery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India RNA Targeting Small Molecule Drug Discovery Market
13.1. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan RNA Targeting Small Molecule Drug Discovery Market
14.1. Japan RNA Targeting Small Molecule Drug Discovery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia RNA Targeting Small Molecule Drug Discovery Market
15.1. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia RNA Targeting Small Molecule Drug Discovery Market
16.1. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea RNA Targeting Small Molecule Drug Discovery Market
17.1. South Korea RNA Targeting Small Molecule Drug Discovery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan RNA Targeting Small Molecule Drug Discovery Market
18.1. Taiwan RNA Targeting Small Molecule Drug Discovery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia RNA Targeting Small Molecule Drug Discovery Market
19.1. South East Asia RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe RNA Targeting Small Molecule Drug Discovery Market
20.1. Western Europe RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK RNA Targeting Small Molecule Drug Discovery Market
21.1. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany RNA Targeting Small Molecule Drug Discovery Market
22.1. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France RNA Targeting Small Molecule Drug Discovery Market
23.1. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy RNA Targeting Small Molecule Drug Discovery Market
24.1. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain RNA Targeting Small Molecule Drug Discovery Market
25.1. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market
26.1. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia RNA Targeting Small Molecule Drug Discovery Market
27.1. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America RNA Targeting Small Molecule Drug Discovery Market
28.1. North America RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA RNA Targeting Small Molecule Drug Discovery Market
29.1. USA RNA Targeting Small Molecule Drug Discovery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada RNA Targeting Small Molecule Drug Discovery Market
30.1. Canada RNA Targeting Small Molecule Drug Discovery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America RNA Targeting Small Molecule Drug Discovery Market
31.1. South America RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil RNA Targeting Small Molecule Drug Discovery Market
32.1. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East RNA Targeting Small Molecule Drug Discovery Market
33.1. Middle East RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa RNA Targeting Small Molecule Drug Discovery Market
34.1. Africa RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. RNA Targeting Small Molecule Drug Discovery Market Regulatory and Investment Landscape
36. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles
36.1. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. RNA Targeting Small Molecule Drug Discovery Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. RNA Targeting Small Molecule Drug Discovery Market Company Profiles
36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
37. RNA Targeting Small Molecule Drug Discovery Market Other Major And Innovative Companies
